Piska, K., Koczurkiewicz, P., Bucki, A., Wójcik-Pszczoła, K., Kołaczkowski, M., & Pękala, E. (2017). Metabolic carbonyl reduction of anthracyclines — role in cardiotoxicity and cancer resistance. Reducing enzymes as putative targets for novel cardioprotective and chemosensitizing agents. Invest New Drugs.
Chicago Style CitationPiska, Kamil, Paulina Koczurkiewicz, Adam Bucki, Katarzyna Wójcik-Pszczoła, Marcin Kołaczkowski, i Elżbieta Pękala. "Metabolic Carbonyl Reduction of Anthracyclines — Role in Cardiotoxicity and Cancer Resistance. Reducing Enzymes As Putative Targets for Novel Cardioprotective and Chemosensitizing Agents." Invest New Drugs 2017.
Cita MLAPiska, Kamil, et al. "Metabolic Carbonyl Reduction of Anthracyclines — Role in Cardiotoxicity and Cancer Resistance. Reducing Enzymes As Putative Targets for Novel Cardioprotective and Chemosensitizing Agents." Invest New Drugs 2017.